These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 730385)

  • 21. Immune labeling of certain strains of Actinomyces naeslundii and Actinomyces viscosus by fluorescence and electron microscopy.
    Lai CH; Listgarten MA
    Infect Immun; 1979 Sep; 25(3):1016-28. PubMed ID: 387589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical and immunological comparison of surface fibrils of strains representing six taxonomic groups of Actinomyces viscosus and Actinomyces naeslundii.
    Masuda N; Ellen RP; Fillery ED; Grove DA
    Infect Immun; 1983 Mar; 39(3):1325-33. PubMed ID: 6188696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mitogenicity for murine splenocytes of specific surface components of the oral periodontopathic bacterium, Actinomyces viscosus.
    Halfpap LM; Brown DA; Clagett JA; Birdsell DC
    Arch Oral Biol; 1985; 30(9):661-6. PubMed ID: 3865642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigens and surface components associated with virulence of Actinomyces viscosus.
    Hammond BF; Steel CF; Peindl KS
    J Dent Res; 1976 Jan; 55():A19-25. PubMed ID: 1060640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the serum antibody responses to type 1 and type 2 fimbriae in mice immunized with Actinomyces viscosus T14V.
    Haber J; Grinnell C
    J Periodontal Res; 1989 Mar; 24(2):81-7. PubMed ID: 2566672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
    Clark WB; Wheeler TT; Cisar JO
    Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic relationships among oral Actinomyces isolates, Actinomyces naeslundii genospecies 1 and 2, Actinomyces howellii, Actinomyces denticolens, and Actinomyces slackii.
    Putnins EE; Bowden GH
    J Dent Res; 1993 Oct; 72(10):1374-85. PubMed ID: 8408879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of surface fibrils from taxonomically typical Actinomyces viscosus WVU627.
    Masuda N; Ellen RP; Grove DA
    J Bacteriol; 1981 Sep; 147(3):1095-104. PubMed ID: 7275934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant low responsiveness in the IgG response of mice to the complex protein antigen type 1 fimbriae from Actinomyces viscosus T14V.
    Haber J; Paradis G; Grinnell CM
    J Immunol; 1991 Mar; 146(6):1949-54. PubMed ID: 1672336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Actinomyces viscosus antigens in Escherichia coli: cloning of a structural gene (fimA) for type 2 fimbriae.
    Donkersloot JA; Cisar JO; Wax ME; Harr RJ; Chassy BM
    J Bacteriol; 1985 Jun; 162(3):1075-8. PubMed ID: 2860095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae.
    Crawford PC; Clark WB
    Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of superoxide and lactoferrin release from polymorphonuclear leukocytes by the type 2 fimbrial lectin of Actinomyces viscosus T14V.
    Sandberg AL; Mudrick LL; Cisar JO; Metcalf JA; Malech HL
    Infect Immun; 1988 Jan; 56(1):267-9. PubMed ID: 2891619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface-associated properties of Actinomyces strains and their potential relation to pathogenesis.
    Loo CY; Willcox MD; Knox KW
    Oral Microbiol Immunol; 1994 Feb; 9(1):12-8. PubMed ID: 7478749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):73s-79s. PubMed ID: 6108369
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Peros WJ; Gibbons RJ
    Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.